227 related articles for article (PubMed ID: 22642278)
1. Value-based reimbursement in oncology.
Kolodziej M; Hoverman JR
Am J Manag Care; 2012 May; 18(3 Spec No.):SP124-6. PubMed ID: 22642278
[No Abstract] [Full Text] [Related]
2. Partnering with a payer to develop a value-based medical home pilot: a West Coast practice's experience.
Bosserman LD; Verrilli D; McNatt W
Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP88-90. PubMed ID: 22693987
[No Abstract] [Full Text] [Related]
3. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low E;
J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
[No Abstract] [Full Text] [Related]
4. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
Freeman RA
J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
[No Abstract] [Full Text] [Related]
5. Managing oncology costs.
Reeder CE; Gordon D
Am J Manag Care; 2006 Feb; 12(1 Suppl):S3-16; quiz S17-9. PubMed ID: 16478368
[TBL] [Abstract][Full Text] [Related]
6. Significant payment decreases to freestanding cancer centers that provide high-dose-rate brachytherapy.
Smith-Fuss W
J Am Coll Radiol; 2009 May; 6(5):372-3. PubMed ID: 19394579
[No Abstract] [Full Text] [Related]
7. Does reimbursement affect physician decision making?
Bennett CL; Stinson TJ
Cancer Treat Res; 2000; 102():137-49. PubMed ID: 10650485
[No Abstract] [Full Text] [Related]
8. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD
J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
[No Abstract] [Full Text] [Related]
9. Plans and oncologists don't see eye to eye on prior authorization.
Reinke T
Manag Care; 2011 Sep; 20(9):14-6. PubMed ID: 21991856
[No Abstract] [Full Text] [Related]
10. Oncology hit hard by SGR debacle. An interview with Allen S. Lichter.
Lichter AS
Am J Manag Care; 2012 May; 18(3 Spec No.):SP143-4. PubMed ID: 22642286
[No Abstract] [Full Text] [Related]
11. [Thinking of oncology. Oncologic aspects in the report of the Hungarian Court of Auditors I].
Telekes A
Orv Hetil; 2008 Feb; 149(8):369-71. PubMed ID: 18281235
[No Abstract] [Full Text] [Related]
12. [Health economics of oncology care: financial effect of performance volume limit (PVL)].
Boncz I; Donkáné Verebes E; Oberfrank F; Kásler M
Magy Onkol; 2010 Mar; 54(1):35-9. PubMed ID: 20350866
[TBL] [Abstract][Full Text] [Related]
13. Enlightened oncologists can provide quality cancer care at reduced costs.
Devi CR
J Surg Oncol; 2014 Nov; 110(6):643-4. PubMed ID: 25125148
[No Abstract] [Full Text] [Related]
14. Oncology reimbursement overview: drug purchasing arrangements and profitability.
Crisafulli T
Semin Oncol; 2008 Aug; 35(4):321-3. PubMed ID: 18692681
[No Abstract] [Full Text] [Related]
15. Funding Cancer Quality Improvement: Payer's Perspective.
Schumacher H
J Oncol Pract; 2015 May; 11(3):180-1. PubMed ID: 25804984
[No Abstract] [Full Text] [Related]
16. Key factors impacting the delivery and financing of oncology care in the United States.
Goldsmith PJ; Paivanas T
J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
[No Abstract] [Full Text] [Related]
17. Cost of cancer care: issues and implications.
Meropol NJ; Schulman KA
J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
[TBL] [Abstract][Full Text] [Related]
18. The impact of reimbursement on quality cancer care.
Mortenson LE
Bus Health; 1988 May; 5(7):38-40. PubMed ID: 10287398
[No Abstract] [Full Text] [Related]
19. Not at any cost: organizations help patients cope with costs of cancer care.
Printz C
Cancer; 2011 Mar; 117(5):879. PubMed ID: 21351079
[No Abstract] [Full Text] [Related]
20. Economic evaluation in radiology: reviewing the literature and examples in oncology.
Bresnahan BW
Acad Radiol; 2010 Sep; 17(9):1090-5. PubMed ID: 20634104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
